Galera Therapeutics Inc expected to post a loss of 83 cents a share - Earnings Preview

Galera Therapeutics

06/08/2021 12:31

* Galera Therapeutics Inc  GRTX.OQ   GRTX.O  is expected to show
a no change in quarterly revenue when it reports results on
August 9 (estimated). 
​* Refinitiv's mean analyst estimate for Galera Therapeutics Inc
is for a loss of 83 cents per share. For the same quarter last
year, the company reported a loss of 75 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Galera
Therapeutics Inc is $19​, about 56.1% above​ its last closing
price of $8.35. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.84       -0.83      -0.75     Beat    9.7
 Dec. 31 2020  -0.68       -0.71      -0.80     Missed  -13
 Sep. 30 2020  -0.77       -0.77      -0.69     Beat    10.5​
 Jun. 30 2020  -0.76       -0.76      -0.75     Beat    1.1
 Mar.          -0.70​      -0.70      -0.74     Missed  -6.3​
 31​ 2020​                                              
 Dec. 31 2019  -0.54       -0.55      -1.31     Missed  -137.7
                                                        ​
 This summary was machine generated August 6 at 11:31 GMT.  All
figures in US dollars unless otherwise stated